Diagnosis & Disease Information

Researchers sought to determine whether N-AVD would continue to show a high response rate in patients with early-stage, unfavorable Hodgkin lymphoma.

Researchers sought to determine whether first-line brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine would yield favorable results in HL.

Researchers sought to determine whether a novel clinical prediction model would be able to determine patient prognosis in advanced-stage classical Hodgkin lymphoma.

Researchers sought to determine whether combining nivolumab with chemotherapy and radiotherapy would be effective in early-stage, unfavorable Hodgkin lymphoma.